Health Insurance (Section 3C Co-Dependant Pathology Services) Amendment Determination (No. 1) 2023 (Cth)

Health Insurance (Section 3C Co-Dependant Pathology Services) Amendment Determination (No. 1) 2023

I, Mary Warner, delegate of the Minister for Health and Aged Care, make the following Determination.

Dated   17 August 2023  

Mary Warner

Assistant Secretary
Diagnostic Imaging and Pathology Branch

Medicare Benefits and Digital Health Division

Department of Health and Aged Care

Contents

1  Name........................................................................................................................................ 1

2  Commencement........................................................................................................................ 1

3  Authority.................................................................................................................................. 1

4  Schedules................................................................................................................................. 1

Schedule 1—Amendments  2

Health Insurance (Section 3C Co-Dependent Pathology Services) Determination 2018

1  Name

This instrument is the Health Insurance (Section 3C Co-Dependant Pathology Services) Amendment Determination (No.1) 2023.

2  Commencement

(1)  Each provision of this instrument specified in column 1 of the table commences, or is taken to have commenced, in accordance with column 2 of the table. Any other statement in column 2 has effect according to its terms.

Commencement information
Column 1	Column 2	Column 3
Provisions	Commencement	Date/Details
1.  The whole of this instrument	1 September 2023

Note:          This table relates only to the provisions of this instrument as originally made. It will not be amended to deal with any later amendments of this instrument.

(2)  Any information in column 3 of the table is not part of this instrument. Information may be inserted in this column, or information in it may be edited, in any published version of this instrument.

3  Authority

This instrument is made under subsection 3C(1) of the Health Insurance Act 1973.

4  Schedules

Each instrument that is specified in a Schedule to this instrument is amended or repealed as set out in the applicable items in the Schedule concerned, and any other item in a Schedule to this instrument has effect according to its terms.

Schedule 1—Amendments

Health Insurance (Section 3C Co-Dependent Pathology Services) Determination 2018

1. Schedule 1 (item 72814, column 2)

Repeal the cell, substitute:

Immunohistochemical examination by immunoperoxidase or other labelled antibody techniques using the programmed cell death ligand 1 (PD‑L1) antibody of tumour material from a patient diagnosed with:

(a)non‑small cell lung cancer; or

(b)recurrent or metastatic squamous cell carcinoma of the oral cavity, pharynx or larynx; or

(c)locally recurrent unresectable or metastatic triple-negative breast cancer.